Effects of Body Structures and Function on Actıvıty and Partıcıpatıon in Patıents wıth Carpal Tunnel Syndrome

May 20, 2025 updated by: Emrah Afsar, Kutahya Health Sciences University

Investigation of the Effects of Pain, Proprioception and Electrodiagnostic Findings on Activity and Participation in Patients With Idiopathic Carpal Tunnel Syndrome

The aim of our study is to determine pain, sensation and electrodiagnostic findings in CTS; to examine its effects on activity and participation.

Study Overview

Status

Completed

Conditions

Carpal Tunnel Syndrome

Detailed Description

50 patients aged 20-55 years diagnosed with mild and moderate carpal tunnel syndrome according to AANEM will be included. VAS, LANSS, Boston Carpal Tunnel Questionnaire (Symptom Severity Scale - Functional Status Scale), Q-DASH, hand grip sensitivity measurement, hand pressure sensitivity measurement will be applied to the participants. In order to examine the relationship between body structure and functions (Pain, Sensation, EMG findings) and activity and participation with the AMOS program, the maximum likelihood method will be selected and a structural equation model (SEM) will be established.

Study Type

Observational

Enrollment (Actual)

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Turkey
- - Kutahya, Turkey
    - Kutahya Health Science University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

Patients who applied to the Physical Therapy Department of Kutahya Health Sciences University Hospital and were diagnosed with mild and moderate CTS according to the American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) will be invited to the study.

Description

Inclusion Criteria:

Being diagnosed with mild-moderate CTS
Being between the ages of 20-55
Volunteering to participate in the study

Exclusion Criteria:

Being diagnosed with severe CTS
Have systemic inflammatory disease
Having a disease that can cause polyneuropathy, such as diabetes mellitus
Being receiving psychotherapy
Illiteracy
Have a hearing problem
Have cognitive impairment
Having a pacemaker

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Leeds Assessment Neuropathic Symptoms and Signs (LANSS) Time Frame: 7 minutes	Leeds Assessment Neuropathic Symptoms and Signs (LANSS) scale is a clinical-based tool for identifying pain and patients with predominant neuropathic mechanisms.	7 minutes
Boston Carpal Tunnel Questionnaire Time Frame: 12 minutes	It is a questionnaire used to evaluate symptom severity and functional status in individuals with carpal tunnel syndrome.	12 minutes
Q-DASH Time Frame: 10 minutes	Q-DASH uses 11 items to measure physical function and symptoms in people with any or multiple musculoskeletal disorders of the upper limb.	10 minutes

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Proprioception Assessment Time Frame: 7 minutes	Hand grip sensitivity will be measured with a dynamometer and hand pressure sensitivity will be measured with a Stabilizer Pressure Biofeedback (SBP) instrument.	7 minutes
Visual Analog Scale Time Frame: 2 minutes	Evaluates the severity of pain, scoring between 0-10.	2 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Kutahya Health Sciences University

Investigators

Principal Investigator: Emrah Afsar, Phd, Kutahya Health Sciences University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 5, 2023

Primary Completion (Actual)

October 15, 2023

Study Completion (Actual)

December 15, 2024

Study Registration Dates

First Submitted

August 1, 2023

First Submitted That Met QC Criteria